Study:ACTG120, 1992. Outcome: relapse of histoplasmosis –induction phase
|
Confounding domains |
Measured variable(s) |
Is there evidence that controlling for this variable was unnecessary? |
Is the confounding domain measured validly and reliably? |
OPTIONAL Is failure to adjust for this variable expected to favour intervention or comparator |
Severity of PDH |
Defined – severe disease excluded. |
No |
Yes |
— |
Severity of HIV |
CD4 |
No |
No. Only baseline reported |
— |
Comorbidities and comedications |
Participants receiving concurrent treatment with drugs that interact with ITRA including rifampin were excluded. |
No |
No. Limited data reported |
— |
Cointerventions |
Is there evidence that controlling for this cointervention was unnecessary? |
Is presence of this cointervention likely to favour outcomes in the intervention or comparator? |
ART at time of PDH diagnosis |
No. Report 35/59 using ART at baseline. No further data provided on HIV management. |
— |
Supportive therapy |
Those requiring intensive supportive therapy were excluded. |
— |
Bias domain |
Signalling questions |
Comments |
Risk of bias judgement |
Bias due to confounding |
1.1–1.8 |
Severity of HIV; severity of PDH and comorbidities were not controlled for using appropriate statistical methodology. |
Serious |
Bias in participant selection |
2.1–2.5 |
Selection into the study may have been related to the intervention and outcome as those with less severe histoplasmosis were more likely to be selected; however, start of follow‐up and intervention appear to coincide. |
Moderate |
Bias in classification of intervention |
3.1–3.3 |
Data provided per participant for ITRA levels in non‐responders. Detailed data on ITRA levels not reported for remaining participants. ITRA levels determined dose of intervention. |
Serious |
Bias due to deviations from intended intervention |
4.1–4.6 |
Deviations from intended intervention were consistent with usual practice. Data reported for toxicity and clinical reasons for discontinuation of intervention. |
Low |
Bias due to missing data |
5.1–5.5 |
Data were reasonably complete. |
Low |
Bias in measurement of outcomes |
6.1–6.4 |
Outcome measures were confirmed by laboratory assessments such as blood culture. |
Low |
Bias in selection of reported result |
7.1–7.3 |
Reported results correspond to intended outcomes. |
Low |
Overall bias |
Serious |